Keywords: medimmune, files, maa, laiv, global, biologics, unit
MedImmune files MAA for LAIV
Article | 12 January 2009
MedImmune, the global biologics unit of Anglo-Swedish drug major AstraZeneca, has submitted a Marketing Authorisation Application for its nasal spray ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
